Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan

NCT02648217 PHASE3 COMPLETED Results posted

This trial is conducted in Africa and Asia. The aim of this trial is to compare efficacy and safety of insulin degludec/insulin aspart twice daily and biphasic insulin aspart twice daily in subjects with type 2 diabetes mellitus before, during and after Ramadan.

Details

Lead sponsor	Novo Nordisk A/S
Phase	PHASE3
Status	COMPLETED
Enrolment	263
Start date	Mon Jan 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Sep 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Diabetes
• Diabetes Mellitus, Type 2

Interventions

• insulin degludec/insulin aspart
• biphasic insulin aspart

Countries

South Africa, Malaysia, United Arab Emirates, Lebanon, Algeria, India